Research & Publications

21
Optimizing drug sensitivity assays in patient-derived tumor organoids: a comparison of IC50 estimation methods and experimental parameters
Impact Factor:2.5
Journal:Biology Methods and Protocols
Publication Date:2025-02-13
22
A novel USP4 inhibitor that suppresses colorectal cancer stemness by promoting β-catenin and Twist1 degradation
Impact Factor:6.1
Journal:Journal of Translational Medicine
Publication Date:2025-01-24
23
Mutant KRAS and CK2 Cooperatively Stimulate SLC16A3 Activity to Drive Intrahepatic Cholangiocarcinoma Progression
Impact Factor:12.5
Journal:Cancer Research
Publication Date:2025-01-24
24
PTPN23-dependent activation of PI3KC2α is a therapeutic vulnerability of BRAF-mutant cancers
Impact Factor:12.8
Journal:JOURNAL OF EXPERIMENTAL MEDICINE
Publication Date:2025-01-22
25
One-Step Fabrication of Highly Customizable Porous Core–Shell Microspheres for the Construction of a 3D Physiologically Relevant Perivascular-Endosteal Multi-Microenvironment Model of Breast Cancer Bone Metastasis
Impact Factor:18.5
Journal:Advanced Functional Materials
Publication Date:2025-01-06
26
Manganese is a potent inducer of lysosomal activity that inhibits de novo HBV infection
Impact Factor:5.5
Journal:Plos Pathogens
Publication Date:2025-01-02
27
Transcriptomic and proteomic sequencing unveils the role of vitamin D and metabolic flux shifts in the induction of human hepatic organoids
Impact Factor:7.1
Journal:Stem Cell Research & Therapy
Publication Date:2024-12-18
28
Preparation of 3D Zonal and Interactional Glomerular Models Based on Composite Core−Shell Hydrogel Microspheres
Impact Factor:9.9
Journal:ACS Materials Letters
Publication Date:2024-10-16
29
Sulindac (K-80003) with nab-paclitaxel and gemcitabine overcomes drug-resistant pancreatic cancer
Impact Factor:27.7
Journal:Molecular Cancer
Publication Date:2024-09-30
30
Necroptosis enhances ‘don’t eat me’ signal and induces macrophage extracellular traps to promote pancreatic cancer liver metastasis
Impact Factor:14.7
Journal:Nature Communications
Publication Date:2024-07-18

AimingMed is a leading biotech company specializing in organoid technology.Our techniques empower oncologist with organoid-based drug sensitivity tests, and our AI algorithm facilitate the selection of the most suitable treatment options for patients...

Services

Contact

  • Hangzhou AimingMed Technologies Co., Ltd.
    1st Floor, South Block, Building 10, No.88 Jiangling Road, Binjiang District, Hangzhou, Zhejiang Province, P.R.China
  • Chengdu AimingMed Medical Laboratory Co., Ltd.
    1st Floor, Building 5, No.77 Jinke South Road, Jinniu High-tech Industrial Park, Chengdu, Sichuan Province
  • Chengdu Organoids Biobank
    No.1, 1st Floor, Building 5, No.77, Jinke South Second Road, Jinniu High-tech Industrial Park, Chengdu, Sichuan Province, China
  • Shandong Province Organoids Biobank
    Building 16, Blue Medicine Valley Life Island, No. 17, Donghai Road, Dayao Subdistrict, Muping District, Yantai City, Shandong Province, China
  • AimingMed Singapore Pte.Ltd.
    CSSD International Business Cooperation Centre, BLK 55 Ayer Rajah Crescent #01-01, Singapore 139949
  • 0571-85352695
  • info@aimingmed.com